CDH1 and breast cancer: Highlighting challenges in pathologic diagnosis of ILC, thirty-five pathologists diagnosed NST and ILC from a set of breast cancers and showed only a moderate inter-observer agreement, but a substantial agreement was a found when E-cadherin was also used in the diagnosis5.